Slowing T1D Progression
0.00
This 1-hour webinar will provide the latest updates on T1D autoantibody screening tests and programs, their role in identifying people who have a risk of developing T1D, best practices for monitoring and supporting patients following T1D autoantibody testing, and investigational therapies that may slow T1D progression in individuals with a high risk of developing T1D and those with new-onset T1D.

Upon completion, participants should be able to:
• Recognize the different stages of T1D and the importance of preventing T1D diagnosis in diabetic ketoacidosis
• Explain the benefits and limitations of T1D autoantibody screening tests to patients and families
• Describe monitoring protocols and support resources for individuals who have tested positive for T1D autoantibodies
• Identify therapies currently in clinical trials that may slow T1D progression in individuals with a high risk of developing T1D and in those with new onset T1D